| Filed On | Filing |
|---|---|
| 03 Nov 2026 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, November 3, 2026 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today anno... |
| 23 Jul 2026 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, July 23, 2026 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announc... |
| 19 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
The purpose of the AtriCure, Inc. Amended and Restated 2023 Stock Incentive Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby directors, officers, ... |
| 05 May 2026 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, May 5, 2026 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced... |
| 17 Feb 2026 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, February 17, 2026 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today ann... |
| 12 Jan 2026 |
8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more
This FIRST AMENDMENT TO CREDIT AGREEMENT AND SECURITY AGREEMENT (this “Amendment”), dated as of January 9, 2026, is among ATRICURE, INC. (the “Company”) and ATRICURE, LLC (together with the Company, the “Borrowers”), the other Loan Parti... |
| 29 Oct 2025 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, October 29, 2025 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today anno... |
| 29 Jul 2025 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, July 29, 2025 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announc... |
| 20 May 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
The purpose of the AtriCure, Inc. Amended and Restated 2023 Stock Incentive Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby directors, officers, ... |
| 29 Apr 2025 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, April 29, 2025 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announ... |
| 26 Mar 2025 |
8-K: Regulation FD Disclosure
Analyst and Investor Day Michael Carrel, CEO © 2025 AtriCure, Inc. All rights reserved. March 2025 Exhibit 99.1 |
| 12 Feb 2025 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, February 12, 2025 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today ann... |
| 13 Jan 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Creating a World Class Platform January 2025 © 2025 AtriCure, Inc. All rights reserved. J.P. MORGAN HEALTHCARE CONFERENCE Exhibit 99.2 |
| 29 Oct 2024 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, October 29, 2024 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today anno... |
| 30 Jul 2024 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, July 30, 2024 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announc... |
| 14 May 2024 |
8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
The purpose of the AtriCure, Inc. Amended and Restated 2023 Stock Incentive Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby directors, officers, ... |
| 01 May 2024 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, May 1, 2024 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced... |
| 15 Feb 2024 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, February 15, 2024 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today ann... |
| 08 Jan 2024 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +2 more
U.S. Tax Certificate (For Foreign Lenders that are not Partnerships for U.S. Federal Income Tax Purposes) |
| 04 Jan 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
MASON, Ohio, January 4, 2024—AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announc... |
Loading...